Lymphoma research at the Norwegian Radium Hospital

Harald Holte, leader
Harald Holte, leader
The Lymphoma program consists of clinicians, pathologists and radiologists at the Hospital and researchers at the Cancer Institute with dedication for malignant lymphomas. Both an optimal care and treatment plan for our patients, clinical studies as well as translational and molecular/biological lymphoma research are in focus.

Main focus areas of our research:

1. High dose therapy and stem cell research

2. Immunotherapy

3. Lymphoma biology

4. Late effects and quality of life

We have during the last decade had broad international cooperation with i.e. the Nordic Lymphoma Group and other European study groups like the German and British Lymphoma Groups, the European Bone Marrow Transplantation Group (EBMT) and European Organisation for Research and Treatment of Cancer (EORTC). The Norwegian Radium Hospital is one of three European Hospitals which are members of the Lymphoma and Leukemia Molecular Profiling Project, headed by National Cancer Institute, US.